The insider selling cluster is too small relative to Natera's $40B market cap to convey a meaningful signal. Monitor for any upcoming corporate events (earnings, product announcements) that might have prompted the sales, but the amounts are routine and non-informative.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 7 $281.27entry
- T+1 · 4mo ago −2.45%α −2.14% · $274.39
- T+5 · 4mo ago −3.06%α −3.61% · $272.66
- T+20 · 4mo ago −3.88%α −5.21% · $270.36
- T+60 · 7w ago +46.94%α +44.95% · $413.31
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three Natera insiders (a Director and two C-suite executives) sold a combined ~$9.5M in shares over a 7-day window. The total selling represents only ~0.024% of Natera's $40B market cap, making the cluster immaterial and routine. No bearish signal is warranted given the tiny proportional size.
Key Financial Metrics
Key Facts
- Three insiders sold shares totaling ~$9.5M in a 7-day window (June 24, July 1, 2026).
- Total selling represents only ~0.024% of Natera's $40B market cap.
- Sellers include Director Herm Rosenman, President of Clinical Diagnostics Solomon Moshkevich, and SEC/Chief Legal Officer Daniel Rabinowitz.
- All transactions were open-market sales; no insider purchases occurred in the cluster.
Financial Impact
Insider selling of ~$9.5M, representing 0.024% of market cap, immaterial.
Risk Factors
- No material risk identified from this cluster.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-NTRA-1783386335507 |
Track record
63 reports on NTRA
6 of 9 bullish or bearish reports moved the stock their way by T+1. Best: +6.55% at T+5 after the Oct 2, 2026 report. 6 of 9 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $300.44 Now $288.48 −3.98% settles Nov 17
- Nov 10, 20266d ago Insider Cluster Neutral 3/10 Entry $319.82 to $322.94 Now $288.48 −9.80% ▲ +0.98% +1.33% vs SPY
- Nov 10, 20266d ago S-3ASR Neutral 3/10 Entry $319.82 to $322.94 Now $288.48 −9.80% ▲ +0.98% +1.33% vs SPY
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $310.67 to $320.39 Now $288.48 −7.14% ▲ +3.13% +0.76% vs SPY
- Nov 5, 202611d ago 8-K Mixed 6/10 Entry $310.67 to $320.39 Now $288.48 −7.14% ▲ +3.13% +0.76% vs SPY
- Nov 5, 202611d ago SC 13G Neutral 4/10 Entry $363.76 to $310.67 Now $288.48 −20.69% ▼ −14.59% −14.91% vs SPY
- Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $363.76 to $310.67 Now $288.48 −20.69% ▼ −14.59% −14.91% vs SPY
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $391.03 to $363.76 Now $288.48 −26.23% ▼ −6.97% −2.56% vs SPY
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $388.63 to $391.03 Now $288.48 −25.77% ▲ +0.62% −1.03% vs SPY
- Nov 2, 202614d ago 144 Neutral 3/10 Entry $388.63 to $391.03 Now $288.48 −25.77% ▲ +0.62% −1.03% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers